Bristol Myers Beats on Revenue as Revlimid Sales Decline Slows
Bristol Myers Squibb Co.’s first-quarter revenue beat Wall Street’s expectations as sales of the blockbuster cancer medicine Revlimid didn’t fall as quickly as analysts expected.
Bristol Myers Squibb Co.’s first-quarter revenue beat Wall Street’s expectations as sales of the blockbuster cancer medicine Revlimid didn’t fall as quickly as analysts expected.
Turkey’s central bank kept interest rates unchanged, pausing a month after surprising markets with a big hike and delivering additional tightening since then.
The stakes are high as two of the biggest artificial intelligence players prepare to unveil results, a day after Meta Platforms Inc. alarmed investors with its forecast.
Fewer than one in 10 of Europe’s best-paid bankers are female, new research shows, highlighting the wide gender pay gap in the financial services industry.
Technology stocks dragged down US equity futures on Thursday after a disappointing outlook from Meta Platforms Inc. cranked up the pressure on other tech giants in a high-stakes earnings week.
{{ video.ContentPackages[0].ScheduleStartDateTime | fromNow }}
{{ currentStream.Desc }}